|
145. Hiroi, T., Chow, T., Imaoka, S., and Funae, Y. Catalytic
specificity of CYP2D isoforms in rat and human. Drug Metab. Dispos. 30:
970-976, 2002.
146. Osada, M., Imaoka, S., Sugimoto, T., Hiroi, T., and Funae,
Y. NADPH-cytochrome P-450 reductase in the plasma membrane modulates the
activation of hypoxia-inducible factor 1. J. Biol. Chem., 277:
23367-23373, 2002.
147. Sukata, T., Uwagawa, S., Ozaki, K., Ogawa, M., Nishikawa,
T., Iwai, S., Kinoshita, A., Wanibuchi, H., Imaoka, S., Funae, Y., Okuno, Y.,
and Fukushima, S. Detailed low-dose study of 1,1-bis(p-chlorophenyl)-2,2,2-
trichloroethane carcinogenesis suggests the possibility of a hormetic effect.
Int. J. Cancer, 99: 112-118, 2002.
148. Kinoshita, A., Wanibuchi, H., Imaoka, S., Ogawa, M.,
Masuda, C., Morimura, K., Funae, Y., and Fukushima, S. Formation of
8-hydroxydeoxyguanosine and cell-cycle arrest in the rat liver via generation
of oxidative stress by phenobarbital: association with expression profiles of
p21(WAF1/Cip1), cyclin D1 and Ogg1. Carcinogenesis, 23: 341-349, 2002.
149. Hashizume, T., Imaoka, S., Mise, M., Terauchi, Y., Fujii,
T., Miyazaki, H., Kamataki, T., and Funae, Y. Involvement of CYP2J2 and CYP4F12
in the metabolism of ebastine in human intestinal microsomes. J. Pharmacol.
Exp. Ther., 300: 298-304, 2002.
150. Yamaguchi, Y., Kirita, S., Hasegawa, H., Aoyama, J., Imaoka, S., Minamiyama,
Y., Funae, Y., Baba, T., and Matsubara, T. Contribution of CYP4A8 to the
formation of 20-hydroxyeicosatetraenoic acid from arachidonic acid in rat
kidney. Drug Metab. Pharmacokinet. 17: 109-116, 2002.
151. Kamata, T., Chow, T., Hiroi, T., Imaoka, S., Morimoto, K., Ohde, H., and
Funae, Y. Metabolism of Selegiline hydrochloride, a selective monoamine
B-type inhibitor, in human liver microsomes. Drug Metab. Pharmacokinet.
7: 199-206, 2002.
152. Kojima, Y., Yoshikawa, Y., Ueda, E., Kondo, M.,
Takahashi, S., Matsukura, T., Sakurai, H., Hiroi, T., Imaoka, S., and Funae, Y.
Blood glucose lowering and toxicological effects of zinc (II) complexes with
maltol, threonine, and picolinic acid. Res. Commun. Mol. Pathol. Pharmacol., 112:
91-104, 2002.
153. Ayajiki, K., Fujioka, H., Toda, N., Okada, S.,
Minamiyama, Y., Imaoka, S., Funae, Y., Watanabe, S., Nakamura, A., and Okamura,
T. Mediation of arachidonic acid metabolite(s) produced by endothelial
cytochrome P-450 3A4 in monkey arterial relaxation. Hypertens. Res., 26:
237-243, 2003.
154. Kinoshita, A., Wanibuchi, H., Morimura, K., Wei, M.,
Shen, J., Imaoka, S., Funae, Y., and Fukushima, S. Phenobarbital at low dose
exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage,
altering cell proliferation, apoptosis and gene expression. Carcinogenesis, 24:
1389-1399, 2003.
155. Mizuno, D., Hiroi, T., Ng, P., Kishimoto, W., Imaoka, S.,
and Funae, Y. Regulation of CYP2D expression in rat brain by toluene. Osaka
City Med. J., 49: 49-56, 2003.
156. Mizuno, D., Takahashi, Y., Hiroi, T., Imaoka, S.,
Kamataki, T., and Funae, Y. A novel transcriptional element which regulates
expression of the CYP2D4 gene by Oct-1 and YY-1 binding. Biochim. Biophys.
Acta, 1627: 121-128, 2003.
157. Ng, P.-S., Imaoka, S., Hiroi, T., Osada, M., Niwa, T., Kamataki, T., and Funae, Y. Production of inhibitory polycronal antibodies against cytochrome P450s. Drug Metab. Pharmacokinet. 18: 163-172, 2003.
158. Imaoka, S., Osada, M., Minamiyama, Y., Yukimura, T.,
Toyokuni, S., Takemura, S., Hiroi, T., and Funae, Y. Role of
phenobarbital-inducible cytochrome P450s as a source of active oxygen species
in DNA-oxidation. Cancer Lett., 203: 117-125, 2004.
159. Kishimoto, W., Hiroi, T., Shiraishi, M., Osada, M.,
Imaoka, S., Kominami, S., Igarashi, T., and Funae, Y. Cytochrome P450 2D
catalyze steroid 21-hydroxylation in the brain. Endocrinology, 145:
699-705, 2004.
160. Kubo, T., Maezawa, N., Osada, M., Katsumura, S., Funae, Y.,
and Imaoka, S. Bisphenol A, an environmental endocrine-disrupting chemical,
inhibits hypoxic response via degradation of hypoxia-inducible factor 1
(HIF-1alpha); Structural requirement of bisphenol A for degradation of
HIF-1alpha. Biochem. Biophys. Res. Commun., 318: 1006-1011, 2004.
161. Minamiyama, Y., Takemura, S., Toyokuni, S., Imaoka, S.,
Funae, Y., Hirohashi, K., Yoshikawa, T., and Okada, S. CYP3A induction
aggravates endotoxemic liver injury via reactive oxygen species in male rats.
Free Radic. Biol. Med., 37: 703-712, 2004.
162. Osada, M., Imaoka, S., and Funae, Y. Apigenin suppresses
the expression of VEGF, an important factor for angiogenesis, in endothelial
cells via degradation of HIF-1alpha protein. FEBS Lett. 575: 59-63,
2004.
163. Imaoka, S., Obata, N., Hiroi, T., Osada-Oka, M., Hara,
R., Nishiguchi, S., and Funae, Y. A new epitope of CYP2D6 recognized by liver
kidney microsomal autoantibody from japanese patients with autoimmune
hepatitis. Biol. Pharm. Bull., 28: 2240-2243, 2005.
164. Tanaka, N., Shinkyo, R., Sakaki, T., Kasamastu, M.,
Imaoka, S., Funae, Y., and Yokota, H. Cytochrome P450 2E polymorphism in feline
liver. Biochim. Biophys. Acta, 1726: 194-205, 2005.
165. Okada, K., Hiroi, T., Imaoka, S., and Funae, Y.
Inhibitory effects of environmental chemicals on protein disulfide isomerase in
vitro. Osaka City Med. J., 51:51-63, 2005.
166. Imaoka, S., Hashizume, T., and Funae, Y. Localization of rat cytochrome
P450 in various tissues and comparison of arachidonic acid metabolism of
rat P450 with that of human P450 orthologs. Drug Metab. Phamacokinet. 20: 478-484, 2005.
167. Hiroi, T. Okada, K. Imaoka, S. Osada, M., and Funae, Y. Bisphenol A binds to protein disulfide isomerase and inhibits its enzymatic
and hormone-binding activities. Endocrinology, 147:2773-2780, 2006.
168. Mori, T., Yamazaki, A., Kinoshita, T., and Imaoka, S.
Purification of NADPH-P450 reductase (NPR) from Xenopus laevis and the
developmental change in NPR expression. Life Sci. 79:247-251, 2006.
169. Nakajima, M., Itoh, M., Sakai, H., Fukami, T., Katoh, K., Yamazaki, H.,
Kadlubar, F.F., Imaoka, S., Funae, Y., and Yokoi, T. CYP2A13 expressed in human bladder metabolically activates4-aminobiphenyl.
Int.
J. Cancer, 119: 2520-2526, 2006.
170. Minamiyama, Y., Takemura, S., Imaoka, S., Funae, Y., and Okada, S. Cytochrome P450 is responsible for nitric oxide generation from NO-Aspirin and other organic nitrates. Drug Metab. Pharmacokinet. 22: 15-19,
2007.
171. Imaoka,
S., Muraguchi, T., and Kinoshita, T. Isolation of Xenopus HIF-prolyl 4-hydroxylase and rescue of a small-eye
phenotype caused by Siah2 over-expression. Biochem. Biophys, Res. Commun. 355: 419-425, 2007.
172. Imaoka,
S., Mori. T., and Kinoshita, T. Bisphenol A causes malformation of the head region
in embryos of Xenopus laevis and decreases
the expression of the ESR-1 gene mediated by Notch signaling. Biol.
Pharm. Bull. 30: 371-374, 2007.
173. Okada, K., Imaoka, S., Hashimoto, S., Hiroi, T., and Funae, Y. Over-expression
of protein disulfide isomerase reduces the release of growth hormone induced
by bisphenol A and/or T(3). Mol. Cell Endocrinol. 278: 44-51, 2007.
174. Sawada, T., Kubo, T., Osada-Oka, M., and Imaoka, S.
Effects of ligands for Ah receptor on hypoxic response of cells. Organohalogen
Compounds 69: 1916-1919, 2007.
175. Okada, K., Sawada, T., and Imaoka, S. Differential
response to aryl hydrocarbon receptor ligands in cell types. Organohalogen
Compounds 69: 1866-1869, 2007.
176. Maezawa, N., Tsuchikawa, H., Katsumura, S., Kubo, T., and
Imaoka, S. Synthesis of fluorescent and photoaffinity-labeled derivatives of
bisphenol A and their inhibitory activity toward hypoxic expression of
erythropoietin. Bioorg. Med. Chem. Lett. 17:
5121-1524, 2007.
177. Takemura S., Minamiyama, Y., Toyokuni, S., Imaoka, S., Hai, S., Kubo,
S., Hirohashi, K., Funae, Y., and Okada, S. Overexpression of CYP3A aggravates
endotoxin-induced liver injury in
hypophysectomized female rats. Hepatol Res. 38:70-78, 2008.
178. Osada-Oka, M., Ikeda, T., Imaoka, S., Akiba, S. and Sato, T. VEGF-enhanced proliferation under hypoxia by
an autocrine mechanism in human vascular smooth muscle cells. J.
Atheroscler. Thromb. 15:26-33, 2008.
179. Niwa, T., Okada, K., Hiroi, T., Imaoka, S., Narimatsu, S., and Funae,
Y. Effect of psychotropic
drugs on the 21-hydroxylation of neurosteroids, progesterone and
allopregnanolone, catalyzed by rat CYP2D4 and human CYP2D6 in the brain. Biol. Pharm. Bull. 31:348-351, 2008.
180. Ueda, K.,
Xu, J., Morimoto, H., Kawabe, A., and Imaoka, S. MafG controls hypoxic response
of cells by accumulating HIF-1alpha in the nuclei. FEBS Lett. 582, 2357-2364,
2008.
181. Hashimoto,
S., Okada, K., and Imaoka, S. Interaction between bisphenol derivatives and
protein disulfide isomerase (PDI) and inhibition of PDI functions: Requirement
of chemical structure for binding to PDI. J. Biochem. 144, 335-342, 2008.
182. Suzuki, S., Oguro, A., Osada-Oka, M., Funae, Y., and Imaoka, S. Epoxyeicosatrienoic
acids and/or their metabolites promote hypoxic response of cells. J.
Pharmacol. Sci. 108: 79-88, 2008.
183. Suzuki, S., Oguro, A.,
and Imaoka, S. Modulation of hypoxic response of HUAEC by EETs and DHETs.
Basic.Clin.Pharmacol.102, Supplement 1, 27, 2008.
184. Oguro, A., Suzuki, S.,
and Imaoka, S. Characterization of EET-metabolic enzyme, soluble epoxide
hydrolase. Basic. Clin. Pharmacol. Toxicol. 102, Supplement 1, 27, 2008.
185. Morimoto, H., Ueda,
K., and Imaoka, S. Biological roles of small Maf protein in oxidative stress
and hypoxia response of the cells. Basic. Clin. Pharmacol. Toxicol. 102,
Supplement 1, 44, 2008.
186. Baba, K., Okada, K.,
Kinoshita, T., and Imaoka, S. Bisphenol
A disrupts Notch signaling by inhibiting gamma-secretase activity and causes
eye dysplasia of Xenopus laevis. Toxicol. Sci. 108: 344-355, 2009.
187.
Mandai, T., Fujiwara, S., and Imaoka, S. A novel electron transport system
for thermostable CYP175A1 ffrom Thermus thermophilus HB27. FEBS J. 276:
2416-2429, 2009.
188. Okada,
K., Hashimoto, S., Funae, Y., and Imaoka, S. Hydroxylated polychlorinated biphenyls (PCBs) interact with protein
disulfide isomerase and inhibit its activity. Chem. Res. Toxicol. 22,
899-904, 2009.
189. Mandai, T., Fujiwara, S., and Imaoka, S.
Construction and engineering of a thermostable self-sufficient cytochrome P450.
Biochem. Biophys. Res. Commun. 384, 61-65, 2009.
190. Oguro, A.,
Fujita, N., and Imaoka, S. Regulation of soluble epoxide hydrolase (sEH) in mice with diabetes:
high glucose suppresses sEH expression. Drug Metab. Pharmacokinet. 24, 438-445, 2009.
191. Oguro, A., Sakamoto, K., Suzuki, S., and Imaoka, S. Contribution of hydrolase
and phosphatase domains in soluble epoxide hydrolase to vascular endothelial
growth factor expression and cell growth. Biol. Pharm. Bull. 32, 1962-1967, 2009.
192. Okada,
K., Hashimoto, S., and Imaoka, S. Biological
functions of protein disulfide
isomerase as a target of phenolic endocrine-disrupting chemicals (Review) J. Health Sci. 56: 1-13, 2010.
193. Komurasaki,
R., Imaoka, S., Tada, N., Okada, K., Nishiguchi, S., and Funae, Y. LKM-1 sera from autoimmune
hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2D6. Drug Metab. Pharmacokinet. 25: 84-92, 2010.
194. Osada-Oka, M., Hashiba, Y., Akiba, S., Imaoka, S., and Sato, T. Glucose
is necessary for stabilization of hypoxia-inducible factor-1alpha
under hypoxia: contribution of the pentose phosphate pathway to this
stabilization. FEBS Lett. 584, 3073-3079, 2010.
195.
Kinoshita,
T., Haruta, Y., Sakamoto, C., and Imaoka, S. Antagonistic
role of XESR1 and XESR5 in mesoderm formation in Xenopus laevis. Int. J. Dev. Biol. 55, 25-31, 2011.
196. Imaoka, S. Chemical
stress on protein disulfide isomerases and inhibition of their functions. Int.
Rev. Cell Mol. Biol. 290, 121-166, 2011.
197. Oguro,
A., Sakamoto, K., Funae, Y., and Imaoka, S. Overexpression of CYP3A4, but not
CYP2D6, promotes hypoxic response and cell growth of Hep3B cells. Drug Metab.
Pharmacokinet. 26, 407-415, 2011.
198. Hashimoto,
S., Shiomoto, K., Okada, K., and Imaoka, S. The binding site of bisphenol A to
protein disulfide isomerase (PDI). J. Biochem. 151, 35-45, 2012.
199. Hashimoto,
S., Yoshimura, H., Okada, K., Uramaru, N., Sugihara, K., Kitamura, S., and
Imaoka, S. Effects of polybrominated diphenyl ethers (PBDEs) and their
derivatives on protein disulfide isomerase activity and growth hormone release
of GH3 cells. Chem. Res. Toxicol. 25(3):656-63, 2012.
200. Oguro, A., and Imaoka, S. Lysophosphatidic acids are new substrates for the phosphatase domain
of soluble epoxide hydrolase. J Lipid Res. 53(3):505-512, 2012.
201. Hou, H.H., Hammock, B.D., Su, K.H.,
Morisseau, C., Kou, Y.R., Imaoka,
S., Oguro, A., Shyue, S.K., Zhao, J.F., and Lee, T.S. N-terminal domain of soluble
epoxide hydrolase negatively regulates the VEGF-mediated activation of
endothelial nitric oxide synthase. Cardiovasc Res. 93(1): 120-129, 2012.
202. Hashimoto, S.,
Ito, L., Okumura, M., Shibano, T., Nawata, M., Kumasaka, T., Yamaguchi, H., and
Imaoka, S. Crystallization and preliminary crystallographic analysis of the complex
between triiodothryonine and the bb' fragment of rat protein disulfide
isomerase. Acta Crystallogr Sect F Struct Biol Cryst Commun. 68(Pt 4):476-478, 2012.
203. Hashimoto, S.,
and Imaoka, S. Protein disulfide isomerase regulates the thyroid hormone receptor-mediated
gene expression via redox factor-1 through thiol reduction-oxidation. J. Biol. Chem. 288, 1706-1716, 2013.
204. Baba, K., Morimoto, H., and Imaoka, S. Seven in absentia homolog 2
(Siah2) is a regulator of NF-E2-related factor 2 (Nrf2). J. Biol. Chem. 288, 18393-18405,
2013.
205. Baba, K., Muraguchi, T., and Imaoka, S. Role of the hypoxia response pathway in lens formation during embryonic
development of Xenopus laevis. FEBS Open Bio. 3, 490-495,
2013.
206. Oguro, A.,
Koyama, C., Xu, J., and Imaoka, S. A cellular stress response (CSR) that
interacts with NADPH-P450reductase (NPR) is a new regulator of hypoxic response.
Biochem. Biophys. Res. Commun. 445, 43-47, 2014.
207. Miyake, Y., Hashimoto, S., Sasaki, Y., Kudo, T., Oguro, A.,
and Imaoka, S. Endoplasmic
reticulum protein (ERp) 29 binds as strongly as protein disulfide isomerase
(PDI) to bisphenol A. Chem.
Res. Toxicol. 27, 501-506, 2014.
208. Purba,
E.R., Oguro, A., and Imaoka, S. Isolation and characterization of Xenopus soluble epoxide hydrolase. Biochem.
Biophys. Acta Mol. Cell Biol. Lipid 1841, 954-962, 2014.
209. Okumura,
M., Kadokura, H., Hashimoto, S., Yutani, K., Kanemura, S., Hikima, T., Hidaka,
Y., Ito, L., Shiba, K., Masui, S., Imai, D., Imaoka, S., Yamaguchi, H., and Inaba,
K. Inhibition of
the functional interplay between ER oxidoreduclin-1alpha (Ero1alpha) and protein disulfide isomerase (PDI) by the
endocrine disruptor bisphenol A. J. Biol. Chem. 289, 27004-27018, 2014.
210. Oguro, A., Kobayashi, Y., and Imaoka S. Protein factors and chemical compounds
regulating hypoxic or oxidative stress responses. Pers. Med. Univ. 4, 27-31,
2015.
211. Purba, E.R., Leuhery, E.A., Oguro, A., and Imaoka,
S. The metabolism of lysophosphatidic acids by allelic variants of human soluble
epoxide hydrolase. Drug Metab. Pharmacokinet. 30, 75-81, 2015.
212. Oguro, A., Oida, S., and Imaoka S. Down-regulation of
EPHX2 gene transcription by Sp1 under high-glucose conditions. Biochem J. 470, 281-291,
2015.
213. Siswanto, F.M., Oguro, A., and Imaoka, S. Chlorogenic acid modulates hypoxia
response of Hep3B cells. Pers. Med. Univ.6, 12-16, 2017.
214. Kobayashi, Y., Oguro, A., and Imaoka, S. Bisphenol A and its derivatives
induce degradation of HIF-1alpha via the Lysosomal pathway in human hepatocarcinoma
cell line, Hep3B. Biol. Pharm. Bull. 41, 374-382, 2018.
215. Nakamura, M., Y amanaka, H., Oguro, A., and Imaoka, S. Bisphenol A induces Nrf2-dependent drug-metabolizing enzymes through
nitrosylation of Keap1. Drug Metab. Pharmacokinet. 33, 194-202, 2018.
216. Oguro, A., and Imaoka, S. 14, 15-epoxyeicosatrienoic acid produced by cytochrome
P450s enhances neurite outgrowth of PC12 and rat hippocampal neuronal cells.
Pharmacol. Res. Perspect. 6(5), e00428, 2018.
217. Oguro, A., Imaoka, S. Thioredoxin-related transmembrane protein 2 (TMX2) regulates the Ran protein
gradient and importin-β-dependent nuclear cargo transport. Sci Rep. 9(1), 15296, 2019.
218. Siswanto, F. M., Oguro, A., Arase, S., Imaoka, S. WDR23 regulates the expression of Nrf2-driven
drug-metabolizing enzymes. Drug Metab. Pharmcokinet., 2020, in press.
219. Kobayashi, Y., Oguro, A., Yagi, E., Mitani, A., Kudoh, S., N., Imaoka, S. Bisphenol A and rotenone
induce S-nitrosylation of protein disulfide isomerase (PDI) and inhibit
neurite outgrowth of primary
cultured cells of the rat hippocampus and PC12 cells. J. Toxicol. Sci.
45, 783-794, 2020.
220. Oguro, A., Sugitani, A., Kobayashi, Y., Sakuma, R., Imaoka, S. Bisphenol A stabilizes Nrf2 via Ca2+
influx by direct activation of the IP3 receptor. J. Toxicol. Sci. 46, 1-10,
2021.
221. Kobayashi, Y., Oguro, A., Imaoka, S. Feedback of
hypoxia-inducible factor-1alpha (HIF-1alpha)
transcriptional
activity via redox factor-1 (Ref-1) induction by reactive oxygen species (ROS).
Free
Radic. Res., 55, 154-164, 2021.
222. Oguro, A., Ishihara, Y., Siswanto, F. M., Yamazaki, T.,
Ishida, A., Imaishi, H., Imaoka, S.
Contribution of DHA diols (19,20-DHDP) produced by cytochrome P450s and
soluble epoxide hydrolase
to the beneficial effects of DHA supplementation in the brains of rotenone-induced rat models of
Parkinson’s disease. Biochim. Biophys. Acta
Mol. Cell Biol. Lipids. 1866, 2021, 158858.
223. Kobayashi, Y., Oguro, A., Hirata, Y., Imaoka, S. The regulation of Hypoxia-Inducible Factor-1
(HIF-1alpha) expression by Protein Disulfide Isomerase (PDI).
PLoS ONE 16(2): e0246531, 2021.
224. Siswanto F. M., Oguro
A., Imaoka S. Sp1 is a substrate of Keap1 and regulates the activity of
CRL4AWDR23
ubiquitin ligase toward Nrf2. J. Biol. Chem., 296, 2021, 100704.
225. Siswanto F. M., Oguro A., Sakuma R., Imaoka S. Chlorogenic acid activates
Nrf2/SKN-1
and prolongs lifespan of Caenorhabditis elegans by inhibiting CRL4WDR23 activity
via Akt-FOXO3/DAF16-DDB1 pathway. J. Gerontol. Biol Sci. 77(8):1503-1516, 2022.
226. Siswanto, F. M., Tamura, A., Sakuma, R., Imaoka, S., Yeast β-glucan
increases etoposide sensitivity
in lung cancer cell line A549 by suppressing
nuclear factor erythroid 2-related factor 2
via the noncanonical nuclear
factor kappa B pathway. Mol. Pharmacol., 101, 257-273, 2022.
227. Sakuma, R., Kobayashi, M., Kobashi, R., Onishi, M., Maeda, M., Kataoka,
Y., Imaoka, S.,
Brain pericytes acquire stemness via the Nrf2-dependent antioxidant system.
Stem Cells, 40, 641-654,
2022.
228. Siswanto, F. M., Mitsuoka
Y., Nakamura M., Oguro A., and Imaoka S. Nrf2 and Parkin-Hsc70
regulate the expression and protein stability of
p62/SQSTM1 under hypoxia. Sci. Rep. 12(1):
21265, 2022.
|
